News
Advanced Micro Devices (AMD) Reports Next Week: Wall Street Expects Earnings Growth
Advanced Micro Devices (AMD) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus
Assurant (AIZ) Expected to Beat Earnings Estimates: Should You Buy?
Assurant (AIZ) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a
Analysts Estimate Electronic Arts (EA) to Report a Decline in Earnings: What to Look Out for
The market expects Electronic Arts (EA) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus
Grocery Outlet Holding Corp. (GO) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
The market expects Grocery Outlet Holding Corp. (GO) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known
Analysts Estimate Suncor Energy (SU) to Report a Decline in Earnings: What to Look Out for
Suncor Energy (SU) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a
Analysts Estimate Chemours (CC) to Report a Decline in Earnings: What to Look Out for
The market expects Chemours (CC) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is
Analysts Estimate Jacobs Solutions (J) to Report a Decline in Earnings: What to Look Out for
Jacobs Solutions (J) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives
BlackLine (BL) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
BlackLine (BL) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a
Analysts Estimate Energizer Holdings (ENR) to Report a Decline in Earnings: What to Look Out for
Energizer Holdings (ENR) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook
Devon Energy (DVN) Earnings Expected to Grow: Should You Buy?
Devon Energy (DVN) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives
Duke Energy (DUK) Reports Next Week: Wall Street Expects Earnings Growth
The market expects Duke Energy (DUK) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook
Earnings Preview: DHT Holdings (DHT) Q1 Earnings Expected to Decline
DHT Holdings (DHT) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a
SBA Communications Q1 AFFO & Revenues Beat Estimates, '25 View Raised
SBA Communications Corporation SBAC reported first-quarter 2025 adjusted funds from operations (AFFO) per share of $3.18, beating the Zacks Consensus Estimate of $3.12. However, the figure implies a
Sysco (SYY) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
For the quarter ended March 2025, Sysco (SYY) reported revenue of $19.6 billion, up 1.1% over the same period last year. EPS came in at $0.96, compared to $0.96 in the year-ago quarter.
The reported
Paccar (PCAR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended March 2025, Paccar (PCAR) reported revenue of $6.91 billion, down 16% over the same period last year. EPS came in at $1.46, compared to $2.27 in the year-ago quarter.
The
NexPoint Residential Trust Inc. (NXRT) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
For the quarter ended March 2025, NexPoint Residential Trust Inc. (NXRT) reported revenue of $63.22 million, down 6.5% over the same period last year. EPS came in at $0.84, compared to $1.00 in the
Ecolab (ECL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended March 2025, Ecolab (ECL) reported revenue of $3.7 billion, down 1.5% over the same period last year. EPS came in at $1.50, compared to $1.34 in the year-ago quarter.
The
Compared to Estimates, Pfizer (PFE) Q1 Earnings: A Look at Key Metrics
For the quarter ended March 2025, Pfizer (PFE) reported revenue of $13.72 billion, down 7.8% over the same period last year. EPS came in at $0.92, compared to $0.82 in the year-ago quarter.
The
Entergy (ETR) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
For the quarter ended March 2025, Entergy (ETR) reported revenue of $2.85 billion, up 1.9% over the same period last year. EPS came in at $0.82, compared to $0.54 in the year-ago quarter.
The
Best Momentum Stock to Buy for April 29th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, April 29th:
Philip Morris International PM: This company which operates as a tobacco company
Alexandria Q1 AFFO Beats Estimates, 2025 View Lowered
Alexandria Real Estate Equities, Inc. ARE reported first-quarter 2025 adjusted funds from operations (AFFO) per share of $2.30, beating the Zacks Consensus Estimate of $2.28. This compares
Wall Street Analysts Believe SpringWorks Therapeutics (SWTX) Could Rally 42.29%: Here's is How to Trade
Shares of SpringWorks Therapeutics (SWTX) have gained 4.7% over the past four weeks to close the last trading session at $46.18, but there could still be a solid upside left in the stock if
Wall Street Analysts See a 91.92% Upside in NovoCure (NVCR): Can the Stock Really Move This High?
NovoCure (NVCR) closed the last trading session at $18.31, gaining 2.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Wall Street Analysts Think Intellia Therapeutics (NTLA) Could Surge 392.81%: Read This Before Placing a Bet
Intellia Therapeutics, Inc. (NTLA) closed the last trading session at $8.48, gaining 19.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets
Wall Street Analysts Think Impinj (PI) Could Surge 64.58%: Read This Before Placing a Bet
Shares of Impinj (PI) have gained 0.2% over the past four weeks to close the last trading session at $90.84, but there could still be a solid upside left in the stock if short-term price targets of


